New drug may cut infection risk after Half-Matched stem cell transplants

This study tests whether a drug called sargramostim can help restore white blood cells as quickly as the standard drug (G-CSF) after a half-matched stem cell transplant for blood cancers, while possibly lowering the risk of serious infections. About 38 adults with blood cancers like leukemia or lymphoma will receive sargramostim after their transplant. The main goal is to see if white blood cell counts recover within 20 days, and researchers will also track survival and relapse rates for one year.